BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test
- Wednesday, February 8, 2023, 7:05
- Finance
- Add a comment
Single Test on BD MAX™ Molecular Diagnostic System Identifies and Differentiates Multiple Respiratory Infectious Diseases FRANKLIN LAKES, N.J., Feb. 8, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it…
About the Author
adminasapcorp has written 41546 stories on this site.